Tag: nCoV

More American families struggling to afford food. Can food banks cope?

Tina Marie (Ms. Cat)

More American families struggling to afford food. Can food banks cope?

The economic fallout brought on by COVID-19 put millions of families in Ms. White’s shoes. According to the U.S. Department of Agriculture, 35 million Americans were food insecure before the pandemic, a number that may rise to 50 million by the end of the year, says Zuani Villarreal of Feeding America, a nonprofit that supplies food banks.

Virus Avoidance Is Not the Whole of Life

Tina Marie (Ms. Cat)

By Jenin Younes | American Institute of Economic Research | December 11, 2020

Lest you were hopeful that some semblance of normal life will return in 2021, either due to the development of vaccines or the pandemic fizzling out on its own, the New York Times and 700 epidemiologists have news for you. An article that appeared in the paper on December 4, 2020, entitled “How 700 Epidemiologists are Living Now, and What They Think is Next,” with the subheading “They are going to the grocery store again, but don’t see vaccines making life normal right away,” reveals that most in the profession, or at least the vast majority of those interviewed for the piece, believe that masks and some form of social distancing should continue for years, if not forever.

Virus Avoidance Is Not the Whole of Life

Science Magazine Report Praises China’s COVID-19 Vaccine

Tina Marie (Ms. Cat)

Science Magazine Report Praises China’s COVID-19 Vaccine

“If CNPG’s vaccine indeed prevented 86% of infections and 100% of symptomatic disease, it would stand out as the best efficacy data yet,” said the article.

Related:

Great efficacy claimed for another COVID-19 vaccine, this one from China

UAE’s Ministry of Health and Prevention said the vaccine, which contains a chemically inactivated version of the pandemic coronavirus and is given in two doses, had 86% efficacy “against COVID-19 infection”—a phrase that puzzled outsiders, as other vaccines have mainly been assessed for their ability to prevent symptoms. The press release further states that the vaccine completely prevented moderate and severe cases of the disease and raised “no serious safety concerns.”